1. Introduction {#sec1}
===============

*Campylobacter jejuni* (*C. jejuni*) is the most frequent organism associated with acute bacterial gastroenteritis around the world \[[@B1]\]. The high incidence of *Campylobacter* diarrhea, as well as its duration and possible complications, makes it highly important from a socioeconomic perspective \[[@B2]\]. It is estimated to cause 1.3 million human illnesses every year with 96 million cases in 2010 in the United States \[[@B3]\]. The clinical presentation is characterized mainly by abdominal pain and diarrhea. A prodrome phase characterized by fever, rigors, myalgias, and occasional delirium has been described \[[@B2]\]. The most well-known postinfectious neurological complications are Guillain-Barré syndrome (GBS) and Miller-Fisher syndrome (MFS) \[[@B4]\]. Furthermore, worldwide the incidence is 1 to 2 in 100,000 and 1 to 2 in 1,000,000, for GBS and MFS, respectively \[[@B5]\]. Nearly 30--40% of GBS patients had *C. jejuni* infection 2 weeks prior to onset of neurological symptoms \[[@B6]\]. Other less frequent neurological complications include Bickerstaff\'s brainstem encephalitis, acute transverse myelitis, and acute disseminated encephalomyelitis (ADEM) \[[@B4], [@B7]--[@B9]\]. We present a case of *Campylobacter* gastroenteritis presenting with associated encephalopathy in an immunocompetent patient.

2. Case {#sec2}
=======

A twenty-five-year-old female with unremarkable past medical history was brought to the emergency department due to progressive altered mental status. Per family report, the patient was in her usual state of health until one week before this admission when she started to experience abdominal pain and diarrhea. The patient\'s mother described episodes of anxiety and unusual behavior-associated confusion specially the day before admission.

On the day of admission, the patient sought medical attention at an outpatient clinic. While in the office, she became confused and later she experienced a witnessed seizure. The patient received a dose of lorazepam prior to arrival at the hospital. On arrival to the emergency department, she was found unresponsive with a Glasgow Coma Scale of six. She was afebrile and tachycardic with a heart rate of 115 beats per minute. The rest of her vital signs were within normal limits.

Her physical exam was remarkable for generalized decreased muscle tone and no clear focal deficits. The patient was intubated for airway protection. She was given a loading dose of levetiracetam and was admitted to the neurosciences intensive care unit.

Her initial laboratory tests showed respiratory alkalosis with an elevated white blood cell count at 11.6 th/*μ*l with 76.5% of neutrophils. Her complete metabolic panel showed hypokalemia. Her urine toxicology, serum alcohol levels, and urine analysis were unremarkable. *C*-reactive protein was 3.3 mg/dL, and her lactic acid was 1.2 mmol/L. Blood tests are summarized in [Table 1](#tab1){ref-type="table"}.

A brain computed tomography (CT) without contrast showed slightly increased low density in the left occipital white matter compared to the right which increased the suspicion of posterior reversible encephalopathy syndrome (PRES), and these images are shown in [Figure 1](#fig1){ref-type="fig"}. Herpes simplex virus (HSV) encephalitis and autoimmune epilepsy were also considered in the differential diagnosis. The brain CT with perfusion was negative for stroke. Chest X-ray showed atelectatic changes in the right upper lobe. A CT of the abdomen and pelvis was negative for ovarian teratoma. The patient was started on acyclovir for suspected herpetic encephalitis.

A brain magnetic resonance (MRI) was negative for findings supporting the diagnosis of PRES. The electroencephalogram showed no evidence of seizure activity or epileptiform discharges. Lumbar puncture was performed, and the cerebrospinal fluid (CSF) had a clear appearance. The opening pressure was normal. The CSF glucose was elevated at 91 units. The CSF white blood cell count was 3/*μ*L. Further studies on CSF for ruling out meningitis were done, and they included *Cryptococcus neoformans/gattii*, *Cytomegalovirus*, *Enterovirus* CSF, *E. coli* K1, *Hemophilus influenzae*, Human *Parechovirus*, *Listeria monocytogenes*, *Neisseria meningitidis*, *Streptococcus agalactiae*, *Streptococcus pneumoniae*, varicella-zoster, and herpes simplex virus 1, 2, and 6, which were negative; details are shown in [Table 2](#tab2){ref-type="table"}.

The infectious disease team was consulted, and doxycycline was added due to the high prevalence of typhus in the area. Febrile agglutinins, West Nile virus, and fungal serologies were also negative ([Table 1](#tab1){ref-type="table"}).

CSF studies for autoimmune epilepsy, including N-methyl-D-aspartate (NMDA) receptor antibodies, glutamic acid decarboxylase (GAD-65) antibodies, and voltage-gated potassium channel (VGKC) antibodies, were negative for autoimmune epilepsy, the more detailed studies in [Table 2](#tab2){ref-type="table"}. Human immunodeficiency virus was negative. Autoimmune panel was negative for antineutrophil cytoplasmic antibodies (ANCAs), antinuclear antibody (ANA), and double stranded DNA (dsDNA) antibodies.

Due to persistent diarrhea during the initial day of admission, a gastrointestinal infectious panel was ordered and was positive for *C. jejuni* ([Table 3](#tab3){ref-type="table"}).

Based on the clinical scenario of a patient with extraintestinal complications of *Campylobacter* infection, it was decided to start azithromycin 500 mg per mouth for at least 10 days. The patient showed significant improvement after the first dose and recovered over the next few days prior to discharge.

3. Discussion {#sec3}
=============

We are describing a case of *Campylobacter jejuni* gastroenteritis associated with acute encephalopathy in an immunocompetent adult. The complex initial presentation with neurological symptoms makes this clinical scenario a diagnostic challenge due to the unfamiliarity of clinicians with this disease.

*Campylobacter* species belongs to a distinct group of specialized Gram-negative bacteria designated as rRNA superfamily VI \[[@B10]\]. The most important species that can cause human disease are *C. jejuni* and *C. coli* \[[@B11]\]. Campylobacters invade the intestinal epithelium using flagella, high molecular weight plasmids, superficial adhesins, and chemotactic factors \[[@B12]\].

Patients infected with *C. jejuni* gastroenteritis experience acute watery or bloody diarrhea, fever, weight loss, and cramps that last six days on average \[[@B11]\]. Besides the gastrointestinal local infection, *Campylobacter* species also can cause a range of other clinical manifestations or postinfectious immune disorders \[[@B13]\].

While infection with *C. jejuni* can occur in patients of all ages, this infection is more prevalent in toddlers and young adults than in other age groups \[[@B14]\]. Despite most of the neurologic complications associated with *Campylobacter* enteritis have been historically linked to the pediatric population, some of these manifestations have been also described in adults \[[@B9]\].

Our patient had an unusual presentation of *C. jejuni* gastroenteritis associated with acute encephalopathy. Based on her initial symptoms, she was treated with acyclovir for the suspicion of HSV encephalitis. Moreover, the combination of seizures in association with the abnormalities noted in the mentioned neuroimaging raised the initial suspicion for PRES and autoimmune epilepsy. These diagnoses were ruled out with a brain MRI and a CSF autoimmune panel, respectively \[[@B15]--[@B17]\].

Other autoimmune systemic diseases including lupus and vasculitis were ruled out with negative ANCA, ANA, and dsDNA. We also considered ADEM following a *C. jejuni* gastroenteritis in our differential diagnosis. Nonetheless, the MRI did not show increased T2-signal intensity in the white matter which is a characteristic neuroimaging finding in ADEM \[[@B4]\]. Furthermore, patients suffering ADEM only improve with high-dose steroids that our patient never received \[[@B4]\].

Based on Rio Grande Valley demographics with high prevalence of murine typhus in the area, the patient was treated empirically with doxycycline until her agglutinins were negative \[[@B18]\]. In this clinical case, the neurological and gastrointestinal symptoms rapidly resolved once the patient was started on azithromycin for *Campylobacter* gastroenteritis. Azithromycin is the antibiotic of choice, has good coverage for *Campylobacter jejuni*, shortens the duration of symptoms, and decreases resistance compared to fluoroquinolones \[[@B19], [@B20]\].

At this present time, the exact pathophysiology of *Campylobacter* gastroenteritis associated with encephalopathy is unknown, but it is possible that mechanisms involving antibody cross-reactivity may play a role \[[@B9]\]. For example, it is well known that bidirectional signaling exists between the gastrointestinal tract and the brain in Guillain-Barré syndrome after a *C. jejuni* infection, where the outer membrane structures of *Campylobacter* containing sialic acid resemble those seen in the human gangliosides \[[@B9]\].This brings the topic of gut-brain axis, which explains that everything is interconnected: the gut can influence the brain, the brain can influence the gut, and they both can influence and be influenced by the immune system \[[@B21]\].

There are only a few cases of *Campylobacter* gastroenteritis with encephalopathy in immunocompetent population, and one of them went through a similar analysis process of differential diagnoses, obtained similar workup as in our patient based on the neurological symptoms, age of the patient, immunocompetent status, and severity of symptoms onset, with clinical improvement after starting antibiotics \[[@B9]\].

Due to the low prevalence of *Campylobacter*-associated encephalopathy in adults, we do not recommend assuming that mental status changes in a patient presenting with *Campylobacter* gastroenteritis are necessarily associated with the infection. A proper and well-directed workup should be completed to rule out other more frequent and emergent neurological diseases such as bacterial meningitis or vascular disease. We would recommend considering *Campylobacter*-associated encephalopathy in the differential diagnosis of diarrhea associated with mental status changes.
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###### 

Blood studies.

                                              Blood analysis       Result                 Reference range
  ------------------------------------------- -------------------- ---------------------- ---------------------
  Complete blood count                        White blood cell     11.6                   (4.8--10.9) th/*μ*L
  Percent neutrophils                         76.5                 (49.0--77.6) %         
  Percent lymphocytes                         17.7                 (11.8--40.8) %         
  Percent monocytes                           5                    (3.70--11.80) %        
  Percent eosinophils                         0.2                  (0--4.8) %             
  Percent basophils                           0.3                  (0--1.3) %             
  Percent immature granulocytes               0.3                  (0--1) %               
  Hemoglobin                                  12.6                 (10.8--14.7) gm/dL     
  Hematocrit                                  36.8                 (32.2--42.9) %         
  Mean corpuscular volume                     87.4                 (84--96) fL            
  Mean corpuscular hemoglobin                 29.9                 (28.3--32.3) pg        
  Mean corpuscular hemoglobin concentration   34.2                 (29.58--33.75) gm/dL   
  Platelet count                              212                  (146--388) th/*μ*L     
  Red blood cell distribution width CV        12                   (12.20--15.80) %       
  Red blood cell distribution width SD        38.6                 (38.93--51.44) fL      
                                                                                          
  Complete metabolic panel                    Sodium               136                    (132--143) mmol/L
  Potassium                                   3.3                  (3.5--5.1) mmol/L      
  Chloride                                    105                  (98--107) mmol/L       
  Carbon dioxide                              23                   (21--31) mmol/L        
  Creatinine                                  0.7                  (0.6--1.2) mg/dL       
  BUN                                         12                   (7--25) mg/dL          
  Calcium                                     8.8                  (8.6--10.3) mg/dL      
  Glucose                                     119                  (70--113) mg/dL        
  Ammonia                                     30                   (16--53) umol/L        
  AST                                         17                   (13--39) IU/L          
  ALT                                         15                   (7--52) IU/L           
  Alkaline phosphatase                        73                   (34--104) IU/L         
  Albumin                                     4.1                  (3.7--4.9) gm/dL       
                                              Total bilirubin      0.3                    (0.2--1.2) mg/dL
                                                                                          
  Coagulation studies                         PT                   12.9                   (10.6--13) second
  INR                                         1.11                 (0.90--1.10) INR       
  PTT                                         22.8                 (24--36.7) second      
                                                                                          
  Others                                      Sedimentation rate   46                     2--30 mm/hr
  C-reactive protein                          3.3                  \<1 mg/dL              
  Lactic acid                                 1.2                  (0.5--1.99) mmol/L     
  Alcohol serum                               \<10.00              \<10.00 mg/dL          
  Alcohol serum calculation                   \<0.01               \<0.01 gm/dL           
                                                                                          
  Serology                                    ANCA screen^*∗*^     Negative               Negative
  dsDNA                                       1.5                  \<10 IU/mL             
  Symphony ANA screen                         0.1                  \<0.7 ratio            
  Symphony ANA                                0.2                  \<0.7 ratio            
  Complement C3                               156                  (87--200) mg/dL        
  Complement C4                               26                   (19--52) mg/dL         
                                                                                          
  Infectious studies                          HIV antibodies       Nonreactive            Nonreactive
  *Aspergillus flavus* antibody               Negative             Negative               
  *Aspergillus niger* antibody                Negative             Negative               
  *Aspergillus fumigatus* antibody            Negative             Negative               
  *Coccidioides* antibody                     Negative             Negative               
  Histoplasma antibody                        Negative             Negative               
  Blastomycosis antibody                      Negative             Negative               
  Febrile agglutinin panel^*∗*^               Negative             Negative               
  Respiratory viral panel PCR^*∗*^            Negative             Negative               

^*∗*^ANCA screen: p-ANCA, c-ANCA, and atypical p-ANCA. ^*∗*^Febrile agglutinin panel: P-OX19, POX2, P-OXK, and *Brucella*. ^*∗*^Respiratory viral panel includes adenovirus, coronavirus, influenza A, influenza B, human metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, *Enterovirus*, *Bordetella pertussis*, *Chlamydophila pneumoniae*, and *Mycoplasma pneumoniae*.

###### 

CSF studies.

                                 Variable                                       Result         Reference range
  ------------------------------ ---------------------------------------------- -------------- -----------------
  General analysis               CSF appearance                                 Clear          Clear
  CSF WBC                        3                                              0--5/*μ*L      
  CSF RBC                        0                                              0/*μ*L         
  CSF glucose                    91                                             40--70 mg/dL   
  CSF total protein              26                                             15--45 mg/dL   
                                                                                               
  Infectious studies             CSF *Cryptococcus neoformans/gattii* antigen   Not detected   Not detected
  CSF *Cytomegalovirus*          Not detected                                   Not detected   
  CSF *Enterovirus*              Not detected                                   Not detected   
  CSF *Escherichia coli* K1      Not detected                                   Not detected   
  CSF *Hemophilus influenzae*    Not detected                                   Not detected   
  CSF herpes simplex virus 1     Not detected                                   Not detected   
  CSF herpes simplex virus 2     Not detected                                   Not detected   
  CSF human herpes virus 6       Not detected                                   Not detected   
  CSF human *Parechovirus*       Not detected                                   Not detected   
  CSF *Listeria monocytogenes*   Not detected                                   Not detected   
  *Neisseria meningitidis*       Not detected                                   Not detected   
  *Streptococcus agalactiae*     Not detected                                   Not detected   
  *Streptococcus pneumoniae*     Not detected                                   Not detected   
  Varicella-zoster virus         Not detected                                   Not detected   
  CSF West Nile IgM              \<0.90                                         \<0.90         
  CSF culture                    No growth                                      No growth      
                                                                                               
  Autoimmune studies             CSF VGKC antibody                              \<20           \<20 pmol/L
  CSF NMDA receptor antibody     Negative                                       Negative       
  CSF NMDAR1 antibody, CBA       Negative                                       Negative       
  CSF AMPAR1 antibody, CBA       Negative                                       Negative       
  CSF AMPAR2 antibody, CBA       Negative                                       Negative       
  GABABR antibody, CBA           Negative                                       Negative       
  LGI1 antibody, CBA             Negative                                       Negative       
  CASPR2 antibody, CBA           Negative                                       Negative       
  GAD-65                         \<5                                            \<5 IU/mL      

VGKC: voltage-gated potassium channel; NMDA: N-methyl-D-aspartate; AMPAR: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor; GABA: gamma aminobutyric acid B receptor; LGI1: leucine-rich glioma-inactivated 1; CASPR2: contactin-associated protein 2; GAD: glutamic acid decarboxylase.

###### 

Stool studies.

                              Variable                               Result         Reference range
  --------------------------- -------------------------------------- -------------- -----------------
  Gastrointestinal analysis   *Campylobacter*                        Detected       Not detected
                              *Clostridium difficile*                Not detected   Not detected
                              *Plesiomonas shigelloides*             Not detected   Not detected
                              *Salmonella*                           Not detected   Not detected
                              *Yersinia enterocolitica*              Not detected   Not detected
                              *Vibrio*                               Not detected   Not detected
                              *Vibrio cholerae*                      Not detected   Not detected
                              Enteroaggregative *E. coli*            Not detected   Not detected
                              Enteropathogenic *E. coli*             Not detected   Not detected
                              Enterotoxigenic *E. coli*              Not detected   Not detected
                              Shiga-like toxin-producing *E. coli*   Not detected   Not detected
                              *E. coli* O157                         Not detected   Not detected
                              *Shigella*/enteroinvasive *E. coli*    Not detected   Not detected
                              *Cryptosporidium*                      Not detected   Not detected
                              *Cyclospora cayetanensis*              Not detected   Not detected
                              *Entamoeba histolytica*                Not detected   Not detected
                              *Giardia lamblia*                      Not detected   Not detected
                              Adenovirus                             Not detected   Not detected
                              Astrovirus                             Not detected   Not detected
                              Norovirus                              Not detected   Not detected
                              Rotavirus                              Not detected   Not detected
                              Sapovirus                              Not detected   Not detected
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